[144] Surgery Partners, Inc. SEC Filing

Rhea-AI Filing Summary

Surgery Partners, Inc. (SGRY) Form 144 shows a proposed sale of 25,000 common shares through UBS on 09/16/2025, with an aggregate market value reported as $541,517.60. The shares were acquired on 09/16/2025 via equity compensation and the payment/nature is listed as an equity option exercise. The filing also discloses that the same account (Wayne DeVeydt) sold a total of 367,579 common shares in the prior three months for aggregate gross proceeds of $8,267,200. The filing lists 128,209,410 shares outstanding, and the planned sale is to occur on the NASDAQ through UBS Financial Services.

Insights

Securities Analyst

TL;DR: Insider has recently sold substantial shares; a new 25,000-share sale is planned following an equity option exercise.

The filing documents routine compliance with Rule 144 for the proposed sale of 25,000 common shares acquired the same day via equity compensation and exercised as an option. Material prior activity is disclosed: 367,579 shares sold over the past three months generating roughly $8.27 million in gross proceeds. For analysts, the combination of recent option exercise plus rapid planned sale is a factual data point on insider liquidity and recent trading volume tied to this individual. This report does not include any statements about undisclosed material information; it is a regulatory notice of intent to sell and recent sales history.

Corporate Governance Specialist

TL;DR: Filing is a standard Rule 144 notice showing option exercise and multiple recent insider sales.

The Form 144 provides the required representations and signatures and lists the broker, proposed sale date, and acquisition details. It confirms the seller represents no undisclosed material adverse information. The documented sales over the prior three months and the current planned sale are disclosures relevant to governance and insider trading transparency. The filing itself is procedural and does not assert any new operational or financial developments for the issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	25000	541517.6	128209410	09/16/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	09/16/2025	equity compensation	Surgery Partners, Inc.			25000	09/16/2025	equity option exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/21/2025	100000	2299011
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/26/2025	25000	572717
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/27/2025	11865	271756
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/02/2025	25000	562150
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/03/2025	25000	560251
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/04/2025	25000	562756
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/05/2025	25000	563682
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/08/2025	2014	45207
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/11/2025	100000	2200741
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/12/2025	28700	628929

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Surgery Partners (SGRY) Form 144 disclose about the proposed sale?

It discloses a proposed sale of 25,000 common shares via UBS on 09/16/2025 with aggregate market value $541,517.60

How many shares did the insider sell in the past three months and for how much?

The insider sold 367,579 common shares in the prior three months for aggregate gross proceeds of $8,267,200

How were the 25,000 shares being offered on 09/16/2025 acquired?

The shares were acquired on 09/16/2025 via equity compensation and the payment type is listed as an equity option exercise

Through which broker and exchange is the proposed sale planned?

Broker: UBS Financial Services Inc., Exchange: NASDAQ

How many total shares outstanding does the filing report?

The filing reports 128,209,410 shares outstanding